159 related articles for article (PubMed ID: 30535745)
1. Monitoring response of advanced Merkel cell carcinoma to Avelumab with
Vellani C; D'Ambrosio D; Licata L; Vacchieri I; Bernardo A; Trifirò G
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1197-1198. PubMed ID: 30535745
[No Abstract] [Full Text] [Related]
2. 18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab.
Eshghi N; Lundeen TF; MacKinnon L; Avery R; Kuo PH
Clin Nucl Med; 2018 May; 43(5):e142-e144. PubMed ID: 29538029
[TBL] [Abstract][Full Text] [Related]
3. Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT-confirmed complete response.
Zijlker LP; Levy S; Wolters W; van Thienen JV; van Akkooi ACJ; Tesselaar MET
Cancer; 2024 Feb; 130(3):433-438. PubMed ID: 37788133
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru A; Quon A; McDougall IR; Gambhir SS
Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET/CT for Spontaneous Regression of Metastatic Merkel Cell Carcinoma: Friend or Foe?
Berkowitz AS; Neuman T; Frenkel S; Eliashar R; Weinberger JM; Hirshoren N
Isr Med Assoc J; 2019 Jan; 21(1):63-64. PubMed ID: 30685912
[No Abstract] [Full Text] [Related]
6. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous Merkel cell carcinoma: role of 18FDG PET-CT].
Amal G; Sara T; Ghofrane CS; Malika AI; Majdouline H; Souha S; Abdelatif B; Najoua T; Ghita B; Zineb B; Nabil C
Pan Afr Med J; 2016; 23():156. PubMed ID: 27303574
[TBL] [Abstract][Full Text] [Related]
8. Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
Ishiyama M; Behnia F; Vesselle H
AJR Am J Roentgenol; 2021 Mar; 216(3):776-780. PubMed ID: 33474987
[No Abstract] [Full Text] [Related]
9. Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
Ben-Haim S; Garkaby J; Primashvili N; Goshen E; Shapira R; Davidson T; Israel O; Epelbaum R
Nucl Med Commun; 2016 Aug; 37(8):865-73. PubMed ID: 27092665
[TBL] [Abstract][Full Text] [Related]
10. Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.
Epstude M; Tornquist K; Riklin C; di Lenardo F; Winterhalder R; Hug U; Strobel K
Clin Nucl Med; 2013 Apr; 38(4):283-4. PubMed ID: 23429397
[TBL] [Abstract][Full Text] [Related]
11. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
George A; Girault S; Testard A; Delva R; Soulié P; Couturier OF; Morel O
Nucl Med Commun; 2014 Mar; 35(3):282-90. PubMed ID: 24240193
[TBL] [Abstract][Full Text] [Related]
12. Primary parotid Merkel cell carcinoma: a first imagery and treatment response assessment by 18F-FDG PET.
Giroulet F; Tabotta F; Pomoni A; Prior J
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30852509
[No Abstract] [Full Text] [Related]
13. 15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.
Byrne K; Siva S; Chait L; Callahan J; Bressel M; Seel M; MacManus MP; Hicks RJ
J Nucl Med; 2015 Sep; 56(9):1328-33. PubMed ID: 26159592
[TBL] [Abstract][Full Text] [Related]
14. 18 F-FDG and 18 F-AIF-NOTA-Octreotide PET/CT Confirmed a Rare Case of Cutaneous Merkel Cell Carcinoma With a Solitary Local Nodal Metastasis.
Mi Y; Jia Y; Du D; Du Y; Zhao M
Clin Nucl Med; 2024 Feb; 49(2):204-205. PubMed ID: 38108823
[TBL] [Abstract][Full Text] [Related]
15. Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03.
Poulsen M; Macfarlane D; Veness M; Estall V; Hruby G; Kumar M; Pullar A; Tripcony L; Rischin D
J Med Imaging Radiat Oncol; 2018 Jun; 62(3):412-419. PubMed ID: 29405630
[TBL] [Abstract][Full Text] [Related]
16. PET/CT imaging of metastatic Merkel cell carcinoma to the adrenal glands.
Greene G; Mezheritskiy I; Biko DM
BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22789832
[No Abstract] [Full Text] [Related]
17. Retrospective study on the correlation between 18-fluorodeoxyglucose uptake in positron emission tomography-computer tomography and tumour volume, cytological activity as assessed with Ki-67 and GLUT-1 staining in 10 cases of Merkel cell carcinoma.
Kitamura S; Yanagi T; Inamura-Takashima Y; Imafuku K; Hata H; Uehara J; Ishida Y; Otsuka A; Hirata K; Shimizu H
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e285-e287. PubMed ID: 29377285
[No Abstract] [Full Text] [Related]
18. Complementary role of positron emission tomography in merkel cell carcinoma.
Lin O; Thomas A; Singh A; Greenspan B
South Med J; 2004 Nov; 97(11):1110-2. PubMed ID: 15586604
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS
Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452
[TBL] [Abstract][Full Text] [Related]
20. In brief: Avelumab (Bavencio) for metastatic merkel cell carcinoma.
Med Lett Drugs Ther; 2017 Jul; 59(1521):e120. PubMed ID: 28699934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
